Search

everythinglearnresearchcommunity

for

Search:↓

QIA-64 software can measure straight wire lengths accurately but needs improvement for curved wires and width measurements.

Current automatic metrics for long-form question answering don't align with human preferences; a multi-faceted evaluation approach is needed.

C-scores can help predict gain-of-function and loss-of-function mutations.

The DLQI is a key tool for measuring quality of life in dermatology.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Disease-specific tools better assess alopecia areata's impact on quality of life.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

ALUDWIG can help standardize female hair loss assessment from a single image.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

Current methods can't accurately predict which long-form answers people prefer; evaluations should consider different answer qualities separately.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Disease-specific tools better assess quality of life in alopecia areata patients.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Healthier hair and scalp improve mental wellbeing.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

SQSTM1 gene issues may increase the risk of alopecia areata.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

The protocol is easy to use, but reliable results need the same person to assess each time.

QMSI is a valuable method for studying drug penetration in skin tissues.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

The document reports three sisters with Woodhouse-Sakati syndrome showing typical symptoms and unusual gynecological anomalies.